Regulatory Roundup: FDA and Georgetown University Form Innovation Partnership - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: FDA and Georgetown University Form Innovation Partnership

ePT--the Electronic Newsletter of Pharmaceutical Technology

FDA and Georgetown University Medical Center have entered a partnership to stimulate innovation in regulatory science, ethics, education, and training, according to a Feb. 24, 2011, agency press announcement. Joint activities will include: research and public-health activities in areas such as novel technologies, public health preparedness, ethics, and bioinformatics; mentorship of doctoral and postdoctoral students in collaborative research relevant to FDA’s mission; scientific staff exchanges and professional-development opportunities, including selected FDA staff serving as adjunct faculty in teaching and clinical activities at Georgetown and selected Georgetown staff participating in research and other activities with FDA; and shared access to and development of important training and continuing education activities.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here